Rapid Microbiology Testing Market: Growth, Size, Share, and Trends
Rapid Microbiology Testing Market by Product (Instruments (Mass Spectrometers), Consumables), Method (Nucleic Acid-based), Application (Industrial Testing (Food & Beverage), Clinical Diagnosis), End User (Hospitals), & Region - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The rapid microbiology testing market is projected to reach USD 9.00 billion by 2031 from USD 5.69 billion in 2026, at a CAGR of 9.6%. The rapid microbiology testing market is driven by the rising prevalence of infectious diseases, increasing demand for faster microbial detection, growing pharmaceutical and biopharmaceutical production, and stringent contamination control regulations. Advancements in molecular diagnostics, automation technologies, and rapid sterility testing systems are further supporting market growth globally.
KEY TAKEAWAYS
-
BY REGIONThe Asia Pacific region is expected to witness the fastest growth in the rapid microbiology testing market, driven by expanding healthcare infrastructure, increasing pharmaceutical and biopharmaceutical manufacturing, and rising adoption of rapid molecular diagnostic technologies in countries such as China, India, Japan, and South Korea.
-
BY PRODUCTBy product, reagents & kits accounted for the largest share of 52.4% in 2025, primarily due to their recurring usage across sterility testing, microbial identification, PCR assays, and contamination monitoring workflows in clinical and industrial settings.
-
BY METHODBy method, growth-based rapid microbiology testing accounted for the largest market share of 40.2% in 2025 due to its widespread use in pharmaceutical sterility testing, environmental monitoring, food safety testing, and clinical microbiology applications.
-
BY APPLICATIONBy application, the industrial testing segment accounted for the largest market share of 56.8% in 2025, supported by rising demand for sterility assurance, contamination control, and regulatory compliance in pharmaceuticals, food & beverages, and environmental testing industries.
-
BY END USERBy end user, pharmaceutical & biotechnology companies are projected to witness the highest CAGR during the forecast period due to the increasing adoption of rapid sterility testing and microbial monitoring solutions in biopharmaceutical manufacturing and quality control processes.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSbioMérieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific, Inc. (US) were identified as star players, which correspondingly are supported by their strong market presence and extensive product portfolios.
-
COMPETITIVE LANDSCAPE - STARTUPS/SMEsDon Whitley Scientific Limited (UK), Gradientech (Sweden), Rqmicro AG (Switzerland), and Colifast AS (Norway) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The rapid microbiology testing market is experiencing growth due to the rising prevalence of infectious diseases, increasing incidence of healthcare-associated infections, and growing demand for faster microbial detection methods across healthcare and industrial settings. The expansion of pharmaceutical and biopharmaceutical manufacturing activities is increasing the need for rapid sterility testing and contamination control solutions. Additionally, advancements in molecular diagnostics, laboratory automation, PCR technologies, and automated microbial identification systems are improving testing efficiency and turnaround times.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The influence of end users on the rapid microbiology testing market is driven by the increasing demand for faster microbial detection, stringent contamination control requirements, and the growing adoption of automated diagnostic technologies. Key end users of rapid microbiology testing solutions include hospitals, clinical laboratories, pharmaceutical & biotechnology companies, food & beverage manufacturers, environmental testing laboratories, and research institutions. High-growth applications in this market include infectious disease diagnosis, sterility testing, antimicrobial susceptibility testing, pharmaceutical quality control, food safety testing, environmental monitoring, and biopharmaceutical manufacturing.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
-
Technological advancements in automated microbiology and MALDI-TOF platforms
Level
-
High capital investments and low cost-benefit ratio
-
Regulatory complexity and limited reimbursement coverage
Level
-
Growing demand for rapid microbiology testing in emerging economies
-
Expansion of rapid microbial testing applications
Level
-
Workflow inefficiencies and skilled workforce shortages
-
High investment in automated microbial identification systems
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
The rising prevalence of healthcare-associated infections, antimicrobial-resistant pathogens, and infectious diseases is significantly increasing the demand for rapid microbiology testing solutions. Healthcare providers and pharmaceutical manufacturers are increasingly adopting rapid microbial detection technologies to enable faster diagnosis, improve infection control, and support timely treatment decisions.
Restraint: High capital investments and low cost-benefit ratio
The adoption of advanced rapid microbiology testing systems is often limited due to high capital investment requirements associated with automated instruments, molecular diagnostic platforms, and laboratory automation infrastructure. In addition, maintenance costs, software integration expenses, and the need for skilled laboratory personnel can increase operational costs, particularly for small and mid-sized laboratories.
Opportunity: Growing demand for rapid microbiology testing in emerging economies
Emerging economies present significant growth opportunities for the rapid microbiology testing market due to expanding healthcare infrastructure, increasing pharmaceutical manufacturing activities, and rising awareness regarding infection control and product safety. Governments and private healthcare organizations in countries such as China, India, Brazil, and Southeast Asian nations are investing heavily in laboratory modernization and molecular diagnostics. Increasing food safety concerns, growing biopharmaceutical production, and rising healthcare expenditure are further expected to drive market expansion in these regions.
Challenge: Workflow inefficiencies and skilled workforce shortages
Operational challenges such as complex laboratory workflows, lack of trained microbiology professionals, and difficulties in integrating advanced rapid testing systems with existing laboratory infrastructure may hinder market growth. In addition, variability in regulatory requirements, validation procedures, and quality assurance standards across regions can create implementation challenges for manufacturers and end users.
RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides automated microbial identification, antimicrobial susceptibility testing, rapid sterility testing, and molecular microbiology solutions for clinical diagnostics and pharmaceutical quality control applications | Enables faster pathogen identification | Improved infection control | Reduced turnaround times | Enhanced regulatory compliance for healthcare and industrial laboratories |
 |
Uses MALDI-TOF mass spectrometry platforms for rapid microbial identification in clinical microbiology and pharmaceutical testing laboratories | Delivers high-throughput microbial identification with improved accuracy | Lower per-test costs | Faster laboratory workflows compared to conventional culture-based methods |
 |
Offers molecular diagnostic systems, automated microbiology instruments, and rapid pathogen detection solutions through its life sciences and diagnostics businesses | Supports rapid detection of infectious pathogens | Enhances laboratory automation | Improves operational efficiency in hospitals and research laboratories |
 |
Develops rapid molecular diagnostic and PCR-based microbiology testing systems for infectious disease detection and antimicrobial resistance monitoring | Improves diagnostic accuracy | Accelerates clinical decision-making | Supports timely treatment interventions in healthcare settings |
 |
Provides PCR systems, culture media, microbial identification platforms, sterility testing solutions, and environmental monitoring products for healthcare and industrial applications | Enhances contamination detection | Supports rapid product release in pharmaceutical manufacturing | Improves microbiology laboratory productivity and quality assurance processes |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The rapid microbiology testing ecosystem comprises manufacturers, distributors, and end users, each playing a critical role in delivering rapid microbial detection and identification solutions. Manufacturers develop and commercialize rapid microbiology instruments, molecular testing systems, and integrated diagnostic platforms. Distributors support product availability and market reach through their global distribution networks. End users, including hospitals, clinical laboratories, pharmaceutical and biotechnology companies, food & beverage manufacturers, and environmental testing laboratories utilize these solutions to accelerate pathogen detection, ensure product quality, support regulatory compliance, and improve operational efficiency.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Rapid Microbiology Testing Market, by Product
In 2025, reagents & kits held the largest share of the rapid microbiology testing market and are expected to maintain their dominance through 2026. This is primarily driven by the recurring demand for culture media, assay kits, primers, probes, stains, and antimicrobial susceptibility testing reagents used in routine microbiology workflows. Increasing testing volumes across hospitals, pharmaceutical companies, and food testing laboratories, along with the growing adoption of molecular microbiology and automated testing platforms, continue to support long-term segmental growth globally.
Rapid Microbiology Testing Market, by Method
In 2025, the growth-based rapid microbiology testing method accounted for the largest maraket share due to the extensive use of this method in sterility testing, environmental monitoring, and microbial contamination detection. These methods are widely adopted because of their strong regulatory acceptance, reliability in detecting viable microorganisms, and compatibility with pharmaceutical quality assurance workflows.
Rapid Microbiology Testing Market, by Application
In 2025, industrial testing applications captured the largest share of the rapid microbiology testing market, driven by increasing demand for sterility assurance, contamination monitoring, and quality control across pharmaceuticals, biopharmaceuticals, food & beverages, and environmental testing industries. Growing regulatory requirements related to product safety and microbial contamination prevention are accelerating the adoption of rapid microbiology technologies. In addition, rising pharmaceutical manufacturing activities and increasing focus on operational efficiency are supporting sustained growth in industrial testing applications globally.
Rapid Microbiology Testing Market, by End User
In 2025, the hospitals, clinical laboratories, & ASCs segment held the largest share of the rapid microbiology testing market due to the rising demand for infectious disease testing and increasing prevalence of healthcare-associated infections. The growing adoption of rapid microbial identification systems, molecular diagnostics, and antimicrobial susceptibility testing solutions in healthcare settings is driving segmental growth. Additionally, increasing emphasis on early diagnosis, faster clinical decision-making, and improved patient outcomes continues to support demand for rapid microbiology testing technologies across hospitals and diagnostic laboratories globally.
REGION
Asia Pacific to be fastest-growing region in global rapid microbiology testing market during forecast period
The Asia Pacific region is expected to experience the highest CAGR in the rapid microbiology testing market from 2026 to 2031, driven by expanding healthcare infrastructure, increasing pharmaceutical and biopharmaceutical manufacturing activities, and rising adoption of rapid molecular diagnostic technologies. Countries such as China, India, Japan, and South Korea are witnessing significant investments in laboratory modernization, infection control programs, and healthcare automation, creasting growth opportunities for the rapid microbiology testing market.
RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX
In the rapid microbiology testing market, bioMérieux (France) stands out as a dominant player (Star) due to its strong portfolio of automated microbial identification systems, antimicrobial susceptibility testing platforms, molecular diagnostics solutions, and rapid sterility testing technologies. The company benefits from its extensive global presence; strong regulatory expertise; and broad customer base across hospitals, clinical laboratories, and pharmaceutical companies. In contrast, Merck KGaA (Germany) is recognized as an emerging leader owing to its expanding portfolio of rapid microbiological testing solutions for pharmaceutical quality control, including rapid sterility testing, microbial contamination detection, and environmental monitoring products. The company continues to strengthen its position through investments in bioprocessing and life science technologies, strategic collaborations, and innovative solutions that support faster and more efficient microbiological quality assurance.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- bioMérieux (France)
- Waters Corporation (US)
- Danaher Corporation (US)
- Abbott Laboratories (US)
- Thermo Fisher Scientific, Inc. (US)
- Bruker Corporation (US)
- QuidelOrtho Corporation (US)
- Sartorius AG (Germany)
- Merck KGaA (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Charles River Laboratories International, Inc. (US)
- Neogen Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Shimadzu Corporation (Japan)
- Rapid Micro Biosystems, Inc. (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 5.22 Billion |
| Market Forecast in 2031 (Value) | USD 9.00 Billion |
| Growth Rate | CAGR of 9.6 % from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion), Volume ( Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
WHAT IS IN IT FOR YOU: RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Country-wise analysis of rapid microbiology testing market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa | Detailed analysis and profiling of up to five additional market players |
|
| Market share analysis and competitive benchmarking of key rapid microbiology testing companies | Further breakdown of the rapid microbiology testing market into specific countries for Rest of Europe, Rest of Asia Pacific, Rest of Latin America, and Rest of Middle East & Africa | Enhanced regional granularity through additional country-level segmentation, including Germany, the UK, France, Italy, Spain, and Rest of Europe; China, Japan, India, South Korea, Australia and Rest of Asia Pacific; Brazil, Mexico, and Rest of Latin America, along with dedicated analysis for the Middle East & Africa; United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa |
| Pricing analysis of rapid microbiology testing consumables and instruments | Country-wise regulatory and reimbursement landscape analysis for rapid microbiology testing | Broadened market segmentation framework with the inclusion of end user segmentation covering hospitals, cinical laboratories, & ASCs, pharmaceutical & biotechnology companies, food & beverage companies, environmental & water testing laboratories, and other end users |
RECENT DEVELOPMENTS
- April 2026 : bioMérieux SA (France) launched BIOFIRE SPOTFIRE for pharmaceutical industries, a rapid molecular mycoplasma testing platform for pharmaceutical QC applications, delivering results in less than one hour.
- March 2026 : bioMérieux (France) received IVDR CE marking for near-patient respiratory and sore throat molecular diagnostic panels for rapid infectious disease detection, in about 15 minutes, across Europe.
- December 2025 : Waters Corporation (US) expanded respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe through IVDR-certified VIASURE assays developed by Certest Biotec for use on the BD MAX System, enhancing automated molecular pathogen detection capabilities.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the rapid microbiology testing market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global rapid microbiology testing market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global rapid microbiology testing market was split into various segments and subsegments:
- List of major players in the product market by region or country
- Product mapping of various rapid microbiology testing manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from rapid microbiology testing products (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
- Summation of revenue of all companies to arrive at the global rapid microbiology testing market size
Data Triangulation
After determining the overall size of the global rapid microbiology testing market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Rapid microbiology testing products are used to rapidly detect, screen, enumerate, and identify microbes and microbial contaminants causing or spreading diseases. These testing procedures include microbial methods that give sensitive and accurate results faster than conventional microbial testing methods.
Key Stakeholders
- Manufacturers and distributors of rapid microbiology tests
- Hospitals & clinics
- Diagnostic centers
- Research & development (R&D) companies
- Clinical research organizations (CROs)
- Research laboratories & academic institutes
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall rapid microbiology testing market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the rapid microbiology testing market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the rapid microbiology testing market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the rapid microbiology testing market
- To benchmark players within the rapid microbiology testing market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of Europe's rapid microbiology testing market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific rapid microbiology testing market into Hong Kong, Taiwan, and others
- Further breakdown of the Rest of Latin American rapid microbiology testing market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asian rapid microbiology testing market into Malaysia, Singapore, Australia, New Zealand, and others
COMPETITIVE LANDSCAPE ASSESSMENT
- Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the rapid microbiology testing market
- Competitive leadership mapping for established players in the US
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Rapid Microbiology Testing Market